These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3746493)

  • 1. Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure.
    Frost JK; Ball WC; Levin ML; Tockman MS; Erozan YS; Gupta PK; Eggleston JC; Pressman NJ; Donithan MP; Kimball AW
    J Occup Med; 1986 Aug; 28(8):692-703. PubMed ID: 3746493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening results in the National Cancer Institute New York study.
    Melamed MR
    Cancer; 2000 Dec; 89(11 Suppl):2356-62. PubMed ID: 11147612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of early cancer by lung cancer screening].
    Saito Y; Takahashi S; Usuda K; Sato M; Sagawa M; Endo C; Fujimura S
    Nihon Rinsho; 1996 May; 54(5):1410-4. PubMed ID: 8965376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical screening for lung cancer: perspective and strategy.
    Kilburn KH
    J Occup Med; 1986 Aug; 28(8):714-8. PubMed ID: 3746496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum screening for lung cancer in radon exposed uranium miners: a comparison of semi-automated sputum cytometry and conventional cytology.
    Marek W; Richartz G; Philippou S; Marek L; Kotschy-Lang N
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):349-61. PubMed ID: 18204147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study.
    Doria-Rose VP; Marcus PM; Szabo E; Tockman MS; Melamed MR; Prorok PC
    Cancer; 2009 Nov; 115(21):5007-17. PubMed ID: 19637354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer screening: the Mayo program.
    Fontana RS; Sanderson DR; Woolner LB; Taylor WF; Miller WE; Muhm JR
    J Occup Med; 1986 Aug; 28(8):746-50. PubMed ID: 3528436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study.
    Payne PW; Sebo TJ; Doudkine A; Garner D; MacAulay C; Lam S; LeRichie JC; Palcic B
    Mayo Clin Proc; 1997 Aug; 72(8):697-704. PubMed ID: 9276595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study.
    Frost JK; Ball WC; Levin ML; Tockman MS; Baker RR; Carter D; Eggleston JC; Erozan YS; Gupta PK; Khouri NF
    Am Rev Respir Dis; 1984 Oct; 130(4):549-54. PubMed ID: 6091505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of routine cytologic screening of sputum for cancer in 800 men consecutively admitted to a tuberculosis service.
    Lazo BG; Feiner LL; Seriff NS
    Chest; 1974 Jun; 65(6):646-9. PubMed ID: 4832267
    [No Abstract]   [Full Text] [Related]  

  • 11. [Processing of preserved sputum specimens].
    Kobayashi Y; Kondou A; Shibata H
    Rinsho Byori; 1985 Feb; Spec No 61():43-50. PubMed ID: 3999415
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary report of the lung cancer detection program in New York.
    Melamed M; Flehinger B; Miller D; Osborne R; Zaman M; McGinnis C; Martini N
    Cancer; 1977 Feb; 39(2):369-82. PubMed ID: 837325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories.
    Kennedy TC; Proudfoot SP; Franklin WA; Merrick TA; Saccomanno G; Corkill ME; Mumma DL; Sirgi KE; Miller YE; Archer PG; Prochazka A
    Cancer Res; 1996 Oct; 56(20):4673-8. PubMed ID: 8840983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult lung cancer beyond bronchoscopic visibility in sputum-cytology positive patients.
    Sato M; Saito Y; Usuda K; Takahashi S; Sagawa M; Fujimura S
    Lung Cancer; 1998 Apr; 20(1):17-24. PubMed ID: 9699183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of lung cancer screening.
    Wilkinson NW; Loewen GM; Klippenstein DL; Litwin AM; Anderson TM
    J Surg Oncol; 2003 Dec; 84(4):234-8. PubMed ID: 14756435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China.
    Qiao YL; Tockman MS; Li L; Erozan YS; Yao SX; Barrett MJ; Zhou WH; Giffen CA; Luo XC; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):893-900. PubMed ID: 9367062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of squamous-cell carcinoma of the lung by sputum cytology: with special reference to correlation of diagnostic accuracy with size and proximal extent of resected tumor.
    Matsuda M; Horai T; Doi O; Kodama K; Tateishi R
    Diagn Cytopathol; 1990; 6(4):248-51. PubMed ID: 2209349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of early lung cancer: results of radiologic and cytologic screening in the Miyagi program.
    Nakada T; Sato H; Saito Y; Fujimura S
    Tohoku J Exp Med; 1987 Jun; 152(2):173-86. PubMed ID: 2820082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for lung cancer.
    McGee JM
    Semin Surg Oncol; 1989; 5(3):179-85. PubMed ID: 2662335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary and recommendations of the workshop on lung cancer.
    Berlin NI
    Cancer; 1974 Jun; 33(6):1744-6. PubMed ID: 4835169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.